Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Huashi Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, affiliated with the Shanghai University of TCM. It is specifically indicated for the treatment of mild to moderate active ulcerative colitis in patients presenting with the 'spleen deficiency and damp-heat' syndrome pattern. The formula is designed to strengthen the spleen and resolve dampness, addressing the core pathological features of the disease according to TCM theory. In clinical studies, it is evaluated for its ability to improve clinical symptoms, enhance quality of life, and promote mucosal healing, often compared to standard aminosalicylate treatments like mesalazine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Huashi Decoction.